Daily chlorproguanil is an effective alternative to daily proguanil in the prevention of Plasmodium falciparum malaria in Kenya. 1994

C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
Department of Community Health, African Medical Research and Education Foundation (AMREF), Nairobi, Kenya.

To test the efficacy of chlorproguanil prophylaxis, 156 malaria-free schoolchildren in the coastal region of Kenya were allocated at random to receive either 7.5 mg chlorproguanil daily, 50 mg chlorproguanil weekly, 100 mg proguanil daily, or 100 mg calcium lactate weekly (placebo). The children were followed up daily for 169 d, by which time Plasmodium falciparum parasitaemia had occurred in 92% of the placebo group, 31% of the daily proguanil group, 38% of the daily chlorproguanil group and 55% of the weekly chlorproguanil group. There was significant reduction (P < 0.001) in the risk of parasitaemia in all the groups receiving chemoprophylaxis. Daily chlorproguanil and daily proguanil were equally effective, and significantly more effective than weekly high dose chlorproguanil. No significant toxicity was reported or observed. Thus daily chlorproguanil 20 mg/60 kg is a cheap and effective alternative to proguanil for chemoprophylaxis.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002727 Proguanil A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent. Chlorguanid,Chloroguanide,Bigumal,Chloriguane,Chloroguanide Hydrochloride,Paludrin,Paludrine,Proguanil Hydrochloride,Hydrochloride, Chloroguanide,Hydrochloride, Proguanil
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
March 1987, Lancet (London, England),
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
June 1995, The Journal of infectious diseases,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
August 2002, The Pediatric infectious disease journal,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
February 1991, The Journal of tropical medicine and hygiene,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
January 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
January 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
June 1996, Lancet (London, England),
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
January 2004, Journal of travel medicine,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
October 1997, Antimicrobial agents and chemotherapy,
C G Nevill, and J D Lury, and M K Mosobo, and H M Watkins, and W M Watkins
January 2021, The Cochrane database of systematic reviews,
Copied contents to your clipboard!